These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 23429089)

  • 1. Composition of hemagglutinin and neuraminidase affects the antigen yield of influenza A(H1N1)pdm09 candidate vaccine viruses.
    Shirakura M; Kawaguchi A; Tashiro M; Nobusawa E
    Jpn J Infect Dis; 2013; 66(1):65-8. PubMed ID: 23429089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Optimization of influenza A vaccine virus by reverse genetic using chimeric HA and NA genes with an extended PR8 backbone.
    Medina J; Boukhebza H; De Saint Jean A; Sodoyer R; Legastelois I; Moste C
    Vaccine; 2015 Aug; 33(35):4221-7. PubMed ID: 26206270
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction and comparison of different source neuraminidase candidate vaccine strains for human infection with Eurasian avian-like influenza H1N1 virus.
    Liu L; Lu J; Zhou J; Li Z; Zhang H; Wang D; Shu Y
    Microbes Infect; 2017 Dec; 19(12):635-640. PubMed ID: 28859895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Segment 2 from influenza A(H1N1) 2009 pandemic viruses confers temperature-sensitive haemagglutinin yield on candidate vaccine virus growth in eggs that can be epistatically complemented by PB2 701D.
    Hussain S; Turnbull ML; Pinto RM; McCauley JW; Engelhardt OG; Digard P
    J Gen Virol; 2019 Jul; 100(7):1079-1092. PubMed ID: 31169484
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [High-yield reassortant virus containing hemagglutinin and neuraminidase genes of pandemic influenza A/Moscowl/01/2009 (H1N1) virus].
    Ignat'eva AV; Rudneva IA; Timofeeva TA; Shilov AA; Zaberezhnyĭ AD; Aliper TI; Kaverin NV; L'vov DK
    Vopr Virusol; 2011; 56(4):9-14. PubMed ID: 21899062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved antigen yield in pandemic H1N1 (2009) candidate vaccine viruses with chimeric hemagglutinin molecules.
    Harvey R; Guilfoyle KA; Roseby S; Robertson JS; Engelhardt OG
    J Virol; 2011 Jun; 85(12):6086-90. PubMed ID: 21490098
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Generation of a Genetically Stable High-Fidelity Influenza Vaccine Strain.
    Naito T; Mori K; Ushirogawa H; Takizawa N; Nobusawa E; Odagiri T; Tashiro M; Ohniwa RL; Nagata K; Saito M
    J Virol; 2017 Mar; 91(6):. PubMed ID: 28053101
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improvement of influenza vaccine strain A/Vietnam/1194/2004 (H5N1) growth with the neuraminidase packaging sequence from A/Puerto Rico/8/34.
    Pan W; Dong Z; Meng W; Zhang W; Li T; Li C; Zhang B; Chen L
    Hum Vaccin Immunother; 2012 Feb; 8(2):252-9. PubMed ID: 22426370
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased hemagglutinin content in a reassortant 2009 pandemic H1N1 influenza virus with chimeric neuraminidase containing donor A/Puerto Rico/8/34 virus transmembrane and stalk domains.
    Jing X; Phy K; Li X; Ye Z
    Vaccine; 2012 Jun; 30(28):4144-52. PubMed ID: 22561313
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a high-yield reassortant influenza vaccine virus derived from the A/Anhui/1/2013 (H7N9) strain.
    Nakamura K; Shirakura M; Suzuki Y; Naito T; Fujisaki S; Tashiro M; Nobusawa E
    Vaccine; 2016 Jan; 34(3):328-33. PubMed ID: 26657023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antigenic Drift of the Influenza A(H1N1)pdm09 Virus Neuraminidase Results in Reduced Effectiveness of A/California/7/2009 (H1N1pdm09)-Specific Antibodies.
    Gao J; Couzens L; Burke DF; Wan H; Wilson P; Memoli MJ; Xu X; Harvey R; Wrammert J; Ahmed R; Taubenberger JK; Smith DJ; Fouchier RAM; Eichelberger MC
    mBio; 2019 Apr; 10(2):. PubMed ID: 30967460
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of an Influenza A Master Virus for Generating High-Growth Reassortants for A/Anhui/1/2013(H7N9) Vaccine Production in Qualified MDCK Cells.
    Suzuki Y; Odagiri T; Tashiro M; Nobusawa E
    PLoS One; 2016; 11(7):e0160040. PubMed ID: 27454606
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Elicitation of Protective Antibodies against a Broad Panel of H1N1 Viruses in Ferrets Preimmune to Historical H1N1 Influenza Viruses.
    Carter DM; Darby CA; Johnson SK; Carlock MA; Kirchenbaum GA; Allen JD; Vogel TU; Delagrave S; DiNapoli J; Kleanthous H; Ross TM
    J Virol; 2017 Dec; 91(24):. PubMed ID: 28978709
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of lentiviral pseudotypes as an alternative to reassortant or Triton X-100-treated wild-type Influenza viruses in the neuraminidase inhibition enzyme-linked lectin assay.
    Biuso F; Palladino L; Manenti A; Stanzani V; Lapini G; Gao J; Couzens L; Eichelberger MC; Montomoli E
    Influenza Other Respir Viruses; 2019 Sep; 13(5):504-516. PubMed ID: 31411006
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Influenza A/PR/8/34 Donor Viruses Imparting High Hemagglutinin Yields to Candidate Vaccine Viruses in Eggs.
    Johnson A; Chen LM; Winne E; Santana W; Metcalfe MG; Mateu-Petit G; Ridenour C; Hossain MJ; Villanueva J; Zaki SR; Williams TL; Cox NJ; Barr JR; Donis RO
    PLoS One; 2015; 10(6):e0128982. PubMed ID: 26068666
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Neuraminidase-Inhibiting Antibody Titers Correlate with Protection from Heterologous Influenza Virus Strains of the Same Neuraminidase Subtype.
    Walz L; Kays SK; Zimmer G; von Messling V
    J Virol; 2018 Sep; 92(17):. PubMed ID: 29925654
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Formation of antibodies against neuraminidase of A/California/07/2009 (H1N1) influenza virus after immunization with live monovalent influenza vaccine].
    Smolonogina TA; Desheva IuA; Shaldzhian AA; Grudinin MP; Rudenko LG
    Zh Mikrobiol Epidemiol Immunobiol; 2011; (6):72-6. PubMed ID: 22308734
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The M segment of the 2009 pandemic influenza virus confers increased neuraminidase activity, filamentous morphology, and efficient contact transmissibility to A/Puerto Rico/8/1934-based reassortant viruses.
    Campbell PJ; Danzy S; Kyriakis CS; Deymier MJ; Lowen AC; Steel J
    J Virol; 2014 Apr; 88(7):3802-14. PubMed ID: 24429367
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development of a high-yield live attenuated H7N9 influenza virus vaccine that provides protection against homologous and heterologous H7 wild-type viruses in ferrets.
    Chen Z; Baz M; Lu J; Paskel M; Santos C; Subbarao K; Jin H; Matsuoka Y
    J Virol; 2014 Jun; 88(12):7016-23. PubMed ID: 24719414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antigenicity of the 2015-2016 seasonal H1N1 human influenza virus HA and NA proteins.
    Clark AM; DeDiego ML; Anderson CS; Wang J; Yang H; Nogales A; Martinez-Sobrido L; Zand MS; Sangster MY; Topham DJ
    PLoS One; 2017; 12(11):e0188267. PubMed ID: 29145498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.